欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3954/001
药品名称Melfalan SUN 50 mg powder and solvent for solution for injection/infusion
活性成分
    • melphalan hydrochloride 50.0 mg
剂型Powder and solvent for solution for injection/infusion
上市许可持有人Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87 2132 JH Hoofddorp The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Melfalanhydrochloride SUN 50 mg poeder en oplosmiddel voor oplossing voor injectie/infusie
互认成员国 - 产品名称
    • Austria (AT)
    • Denmark (DK)
    • Norway (NO)
    • Germany (DE)
      Melphalan SUN
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
许可日期2018/04/24
最近更新日期2023/04/26
药物ATC编码
    • L01AA03 melphalan
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase